Abbott India Reports Strong Financial Results, Signaling Positive Growth Trends in May 2025

Abbott India, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results, announced on May 15, 2025, indicate a stable financial performance during this period. Notably, the company's score has undergone an adjustment, reflecting a shift from 3 to 5 over the past three months. The financial data reveals that Abbott India achieved a Profit After Tax (PAT) of Rs 367.04 crore, marking the highest figure recorded in the last five quarters. This consistent growth in PAT suggests a favorable near-term trend for the company. Additionally, the Earnings per Share (EPS) reached Rs 172.72, also the highest in the same timeframe, indicating an increase in profitability and enhanced earnings for shareholders. These developments highlight Abbott India's ongoing efforts to strengthen its financial standing within the industry. As the company continues to navigate the competitive landscape, the recent evaluation changes reflect its performance trajectory. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.